Impact of delirium on the short term prognosis of advanced cancer patients

Augusto Caraceni, Oriana Nanni, Marco Maltoni, Laura Piva, Monica Indelli, Ermenegildo Arnoldi, Massimo Monti, Luigi Montanari, Dino Amadori, Franco De Conno, Maria Paola Innocenti, Stefania Derni, Laura Fabbri, Cinzia Martini, Ernesto Zecca, Liliana Groff, Marina Marzola, Attilio Gramazio, Costanza Calia, Giorgio CrucianiAndrea Rossi, Paola Turci

Research output: Contribution to journalArticle

142 Citations (Scopus)

Abstract

BACKGROUND. The objective of this study was to evaluate the impact of delirium on the survival of advanced cancer patients also assessed with a validated prognostic score (the palliative prognostic [PAP] score). METHODS. The study population was a prospective multicenter consecutive case series of advanced cancer patients for whom chemotherapy was no longer considered viable and who were referred to palliative care programs. Clinical and biologic prognostic factors included in the PaP score were assessed at study entry. The Confusion Assessment Method criteria were applied to screen patients presenting with delirium. Survival times were measured from time of enrollment and death taken as an outcome. Survival curves were traced with the Kaplan-Meier method and comparison were based on log rank tests. RESULTS. Delirium was found in 109 cases among 393 consecutive patients (27.7%). The diagnosis of delirium was independently associated with male gender, central nervous system metastases, lower performance status, worse clinical prediction of survival, and progestational treatment. The survival curve of patients with delirium was significantly different from the nondelirious patients curve (log rank, 31.6, P <0.0001). The median survival time was 21 days (95% confidence interval [CI], 16-27) for the delirious patients and 39 days (95% CI 33-49) for the others. Multivariate analysis showed that the diagnosis of delirium and PaP score were independently associated with prognosis. CONCLUSIONS. The diagnosis of delirium significantly worsens life expectancy prognosticated with the PaP score. By using the PaP score together with the assessment of cognitive status, physicians can correctly predict patients 30-day survival in greater than 70% of cases. (C) 2000 American Cancer Society.

Original languageEnglish
Pages (from-to)1145-1149
Number of pages5
JournalCancer
Volume89
Issue number5
DOIs
Publication statusPublished - Sep 1 2000

Fingerprint

Delirium
Survival
Neoplasms
Confidence Intervals
Confusion
Biological Factors
Life Expectancy
Palliative Care
Multivariate Analysis
Central Nervous System
Neoplasm Metastasis
Physicians
Drug Therapy

Keywords

  • Advanced cancer
  • Delirium
  • Palliative care
  • Prognostic factors
  • Survival

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Impact of delirium on the short term prognosis of advanced cancer patients. / Caraceni, Augusto; Nanni, Oriana; Maltoni, Marco; Piva, Laura; Indelli, Monica; Arnoldi, Ermenegildo; Monti, Massimo; Montanari, Luigi; Amadori, Dino; De Conno, Franco; Innocenti, Maria Paola; Derni, Stefania; Fabbri, Laura; Martini, Cinzia; Zecca, Ernesto; Groff, Liliana; Marzola, Marina; Gramazio, Attilio; Calia, Costanza; Cruciani, Giorgio; Rossi, Andrea; Turci, Paola.

In: Cancer, Vol. 89, No. 5, 01.09.2000, p. 1145-1149.

Research output: Contribution to journalArticle

Caraceni, A, Nanni, O, Maltoni, M, Piva, L, Indelli, M, Arnoldi, E, Monti, M, Montanari, L, Amadori, D, De Conno, F, Innocenti, MP, Derni, S, Fabbri, L, Martini, C, Zecca, E, Groff, L, Marzola, M, Gramazio, A, Calia, C, Cruciani, G, Rossi, A & Turci, P 2000, 'Impact of delirium on the short term prognosis of advanced cancer patients', Cancer, vol. 89, no. 5, pp. 1145-1149. https://doi.org/10.1002/1097-0142(20000901)89:5<1145::AID-CNCR24>3.0.CO;2-X
Caraceni, Augusto ; Nanni, Oriana ; Maltoni, Marco ; Piva, Laura ; Indelli, Monica ; Arnoldi, Ermenegildo ; Monti, Massimo ; Montanari, Luigi ; Amadori, Dino ; De Conno, Franco ; Innocenti, Maria Paola ; Derni, Stefania ; Fabbri, Laura ; Martini, Cinzia ; Zecca, Ernesto ; Groff, Liliana ; Marzola, Marina ; Gramazio, Attilio ; Calia, Costanza ; Cruciani, Giorgio ; Rossi, Andrea ; Turci, Paola. / Impact of delirium on the short term prognosis of advanced cancer patients. In: Cancer. 2000 ; Vol. 89, No. 5. pp. 1145-1149.
@article{1db609f0659a4f95b03809eef8eaf1fb,
title = "Impact of delirium on the short term prognosis of advanced cancer patients",
abstract = "BACKGROUND. The objective of this study was to evaluate the impact of delirium on the survival of advanced cancer patients also assessed with a validated prognostic score (the palliative prognostic [PAP] score). METHODS. The study population was a prospective multicenter consecutive case series of advanced cancer patients for whom chemotherapy was no longer considered viable and who were referred to palliative care programs. Clinical and biologic prognostic factors included in the PaP score were assessed at study entry. The Confusion Assessment Method criteria were applied to screen patients presenting with delirium. Survival times were measured from time of enrollment and death taken as an outcome. Survival curves were traced with the Kaplan-Meier method and comparison were based on log rank tests. RESULTS. Delirium was found in 109 cases among 393 consecutive patients (27.7{\%}). The diagnosis of delirium was independently associated with male gender, central nervous system metastases, lower performance status, worse clinical prediction of survival, and progestational treatment. The survival curve of patients with delirium was significantly different from the nondelirious patients curve (log rank, 31.6, P <0.0001). The median survival time was 21 days (95{\%} confidence interval [CI], 16-27) for the delirious patients and 39 days (95{\%} CI 33-49) for the others. Multivariate analysis showed that the diagnosis of delirium and PaP score were independently associated with prognosis. CONCLUSIONS. The diagnosis of delirium significantly worsens life expectancy prognosticated with the PaP score. By using the PaP score together with the assessment of cognitive status, physicians can correctly predict patients 30-day survival in greater than 70{\%} of cases. (C) 2000 American Cancer Society.",
keywords = "Advanced cancer, Delirium, Palliative care, Prognostic factors, Survival",
author = "Augusto Caraceni and Oriana Nanni and Marco Maltoni and Laura Piva and Monica Indelli and Ermenegildo Arnoldi and Massimo Monti and Luigi Montanari and Dino Amadori and {De Conno}, Franco and Innocenti, {Maria Paola} and Stefania Derni and Laura Fabbri and Cinzia Martini and Ernesto Zecca and Liliana Groff and Marina Marzola and Attilio Gramazio and Costanza Calia and Giorgio Cruciani and Andrea Rossi and Paola Turci",
year = "2000",
month = "9",
day = "1",
doi = "10.1002/1097-0142(20000901)89:5<1145::AID-CNCR24>3.0.CO;2-X",
language = "English",
volume = "89",
pages = "1145--1149",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "5",

}

TY - JOUR

T1 - Impact of delirium on the short term prognosis of advanced cancer patients

AU - Caraceni, Augusto

AU - Nanni, Oriana

AU - Maltoni, Marco

AU - Piva, Laura

AU - Indelli, Monica

AU - Arnoldi, Ermenegildo

AU - Monti, Massimo

AU - Montanari, Luigi

AU - Amadori, Dino

AU - De Conno, Franco

AU - Innocenti, Maria Paola

AU - Derni, Stefania

AU - Fabbri, Laura

AU - Martini, Cinzia

AU - Zecca, Ernesto

AU - Groff, Liliana

AU - Marzola, Marina

AU - Gramazio, Attilio

AU - Calia, Costanza

AU - Cruciani, Giorgio

AU - Rossi, Andrea

AU - Turci, Paola

PY - 2000/9/1

Y1 - 2000/9/1

N2 - BACKGROUND. The objective of this study was to evaluate the impact of delirium on the survival of advanced cancer patients also assessed with a validated prognostic score (the palliative prognostic [PAP] score). METHODS. The study population was a prospective multicenter consecutive case series of advanced cancer patients for whom chemotherapy was no longer considered viable and who were referred to palliative care programs. Clinical and biologic prognostic factors included in the PaP score were assessed at study entry. The Confusion Assessment Method criteria were applied to screen patients presenting with delirium. Survival times were measured from time of enrollment and death taken as an outcome. Survival curves were traced with the Kaplan-Meier method and comparison were based on log rank tests. RESULTS. Delirium was found in 109 cases among 393 consecutive patients (27.7%). The diagnosis of delirium was independently associated with male gender, central nervous system metastases, lower performance status, worse clinical prediction of survival, and progestational treatment. The survival curve of patients with delirium was significantly different from the nondelirious patients curve (log rank, 31.6, P <0.0001). The median survival time was 21 days (95% confidence interval [CI], 16-27) for the delirious patients and 39 days (95% CI 33-49) for the others. Multivariate analysis showed that the diagnosis of delirium and PaP score were independently associated with prognosis. CONCLUSIONS. The diagnosis of delirium significantly worsens life expectancy prognosticated with the PaP score. By using the PaP score together with the assessment of cognitive status, physicians can correctly predict patients 30-day survival in greater than 70% of cases. (C) 2000 American Cancer Society.

AB - BACKGROUND. The objective of this study was to evaluate the impact of delirium on the survival of advanced cancer patients also assessed with a validated prognostic score (the palliative prognostic [PAP] score). METHODS. The study population was a prospective multicenter consecutive case series of advanced cancer patients for whom chemotherapy was no longer considered viable and who were referred to palliative care programs. Clinical and biologic prognostic factors included in the PaP score were assessed at study entry. The Confusion Assessment Method criteria were applied to screen patients presenting with delirium. Survival times were measured from time of enrollment and death taken as an outcome. Survival curves were traced with the Kaplan-Meier method and comparison were based on log rank tests. RESULTS. Delirium was found in 109 cases among 393 consecutive patients (27.7%). The diagnosis of delirium was independently associated with male gender, central nervous system metastases, lower performance status, worse clinical prediction of survival, and progestational treatment. The survival curve of patients with delirium was significantly different from the nondelirious patients curve (log rank, 31.6, P <0.0001). The median survival time was 21 days (95% confidence interval [CI], 16-27) for the delirious patients and 39 days (95% CI 33-49) for the others. Multivariate analysis showed that the diagnosis of delirium and PaP score were independently associated with prognosis. CONCLUSIONS. The diagnosis of delirium significantly worsens life expectancy prognosticated with the PaP score. By using the PaP score together with the assessment of cognitive status, physicians can correctly predict patients 30-day survival in greater than 70% of cases. (C) 2000 American Cancer Society.

KW - Advanced cancer

KW - Delirium

KW - Palliative care

KW - Prognostic factors

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=0034284081&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034284081&partnerID=8YFLogxK

U2 - 10.1002/1097-0142(20000901)89:5<1145::AID-CNCR24>3.0.CO;2-X

DO - 10.1002/1097-0142(20000901)89:5<1145::AID-CNCR24>3.0.CO;2-X

M3 - Article

C2 - 10964345

AN - SCOPUS:0034284081

VL - 89

SP - 1145

EP - 1149

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 5

ER -